| Value | ₹3,000 Cr |
|---|
BSE filing, NSE: PURVA. Summary written from the filing by ALFA Finder's alert engine.
Puravankara Ltd: key numbers
- Share price
- ₹197.91
- Market cap
- ₹4,693 Cr
- Revenue (annual)
- ₹3,740 Cr
- Net profit (annual)
- ₹63.71 Cr
- P/E (TTM)
- 29.3×Sector 34.5×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 16.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Puravankara Ltd
All →Puravankara Board Meeting Date
Puravankara will hold a board meeting on 2 November 2026 to consider unaudited quarter and half-year results. The trading window stays closed until 4 November 2026.
Puravankara Merger & Restructuring Worth ₹0.01 Cr
Puravankara Limited has incorporated a wholly-owned subsidiary, Burgundyprime Realty Private Limited, by subscribing to 9,999 equity shares for Rs. 0.01 Crore.
- Value
- ₹0.01 Cr
Puravankara Business Update
Puravankara reported Q2FY27 pre-sales of ₹2,136 crore, up 62% YoY, with collections at ₹1,301 crore. The company added 10.74 msft pipeline worth ₹14,100 crore GDV in H1FY27.
- pipeline developable area added
- 10.74 msft
Puravankara Other Announcement
Puravankara Ltd submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as required under SEBI regulations.
Puravankara Capacity Expansion: ₹2,500 Cr Investment
Puravankara signed a JDA for a 12.76-acre Sathanur, Bengaluru parcel with an estimated GDV of ₹2,500 Crore. The 1.90 msft project expands its residential development pipeline.
- Value
- ₹2,500 Cr
- saleable area
- 1.9 msft
Puravankara Debt & Borrowing: ₹25 Cr
Puravankara Limited allotted 250 unlisted non-convertible debentures as the fourth and final tranche, raising ₹25 Crore via private placement.
- Value
- ₹25.00 Cr
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.